Trade MDGL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Madrigal Pharmaceuticals, Inc. (MDGL) is trading at US$521.41, down 0.11% today as of Sep 22, 10:32 EDT. The company has a market capitalisation of US$11.94B. Over the past 52 weeks, MDGL has traded between US$393.61 and US$615.00. On Syfe you can trade MDGL with $0 commission and add it to your watchlist.
| Previous close | US$521.96 |
|---|---|
| Market cap | US$11.94B |
| P/E ratio | 171.49 |
| 52-week range | US$393.61 – US$615.00 |
| Volume | 186.13K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.
Year: 2007
Madrigal Pharmaceuticals Q2 Loss Widens, Revenue Increases
Jul 30, 12:32 PM · MT Newswires
--Earnings Flash (MDGL) Madrigal Pharmaceuticals Posts Q2 Net Loss $1.99 a Share, vs. FactSet Est of $2.68 Loss
Jul 30, 11:13 AM · MT Newswires
-- Earnings Flash (MDGL) Madrigal Pharmaceuticals, Inc. Reports Q2 Revenue $364.3M, vs. FactSet Est of $352.1M
Jul 30, 11:00 AM · MT Newswires
Wells Fargo Initiates Madrigal Pharmaceuticals at Overweight With $685 Price Target
Jul 27, 12:12 PM · MT Newswires
BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $553 From $542
Jul 22, 12:26 PM · MT Newswires
Madrigal Pharmaceuticals, Inc. (MDGL) stock is trading at US$521.41, -0.11% from the previous close of US$521.96.
The market cap for Madrigal Pharmaceuticals, Inc. (MDGL) stock is approximately US$11.94B.
The price-to-earnings ratio for Madrigal Pharmaceuticals, Inc. (MDGL) is 171.49, based on the latest reported earnings.
The 52-week high for Madrigal Pharmaceuticals, Inc. (MDGL) stock is US$615.00.
The 52-week low for Madrigal Pharmaceuticals, Inc. (MDGL) stock is US$393.61.
Madrigal Pharmaceuticals, Inc. (MDGL) does not currently pay a dividend.
Stay on top of MDGL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
